Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7354944 Thiadiazole compounds and methods of use

Patent 7354944 was granted and assigned to Amgen on April, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Date Filed
October 18, 2005
0
Date of Patent
April 8, 2008
0
Patent Application Number
11251846
0
Patent Citations Received
‌
US Patent 12083121 Substituted piperazines as KRAS G12C inhibitors
0
‌
US Patent 11766436 KRAS G12C inhibitors and methods of using the same
‌
US Patent 11905281 KRAS G12C inhibitors and methods of using the same
0
‌
US Patent 11918584 Combination therapy including a KRAS
0
‌
US Patent 11993597 Inhibitors of KRAS G12C and methods of using the same
0
Patent Inventor Names
Guomin Yao
0
Holger Monenschein
0
James Thomas Rider
0
Matthew Paul Bourbeau
0
Qingping Zeng
0
Vellarkad N. Viswanadhan
0
Andrew Tasker
0
Celia Dominguez
0
George Erich Wohlhieter
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7354944
0
Patent Primary Examiner
‌
Rebecca Anderson
0

Find more entities like US Patent 7354944 Thiadiazole compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo